YOLFTbeta
30

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

300534 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

10.22CNY-1.08 (-9.56%)

Price History

Full chart

Market Stats

Previous Close11.30
Open11.00
Day Range10.15 – 11.07
52-Week Range6.78 – 20.96
Volume48.75M
Market Cap3.82B
P/E (TTM)114.36
Forward P/E0.00
EPS0.11
Dividend Yield0.32%
Beta0.22
50-Day Avg14.60
200-Day Avg10.59

About

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and is based in Lanzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Qin Hui Yuan
  • Employees641
  • HeadquartersNo. 138, Jinke Road, Lanzhou, China, 730102, China
  • Websitehttps://www.lsrfzy.com

Leadership

  • Mr. Qin Hui YuanDeputy GM, Secretary of the Board & Director · b. 1975
  • Mr. Bo SunDeputy General Manager · b. 1986
  • Ms. Yue Hong SongGM, Chief Engineer & Director · b. 1974
  • Ms. Rong XiaoChief Financial Officer · b. 1985
  • Mr. Wen Liang ChenDeputy General Manager · b. 1984

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue133.37M212.68M274.89M301.58M277.36M269.68M269.59M203.17M239.00M254.90M287.81M799.68M1.08B1.04B886.96M
Growth (%)-+59.47%+29.25%+9.71%-8.03%-2.77%-0.03%-24.64%+17.64%+6.65%+12.91%+177.85%+35.06%-3.79%-14.64%
Cost of Revenue101.63M161.60M202.39M200.78M169.95M171.95M181.78M117.51M148.60M172.04M195.48M341.62M386.79M288.50M281.43M
Gross Profit31.74M51.07M72.50M100.79M107.41M97.74M87.81M85.65M90.40M82.86M92.33M458.06M693.26M750.57M605.52M
Gross Margin23.80%24.01%26.38%33.42%38.73%36.24%32.57%42.16%37.83%32.51%32.08%57.28%64.19%72.24%68.27%
Operating Expense18.18M23.17M26.81M32.79M37.59M47.62M69.73M72.13M70.87M80.62M101.71M395.75M598.06M644.76M499.96M
Operating Income13.56M27.90M45.70M68.00M69.82M50.11M18.08M13.52M19.53M2.25M-9.38M62.31M95.20M105.81M105.56M
Operating Margin10.17%13.12%16.62%22.55%25.17%18.58%6.71%6.66%8.17%0.88%-3.26%7.79%8.81%10.18%11.90%
EBITDA13.19M29.52M52.23M74.39M76.38M61.61M34.38M31.74M40.63M25.45M18.35M93.16M130.98M144.37M127.51M
EBITDA Margin9.89%13.88%19.00%24.67%27.54%22.85%12.75%15.62%17.00%9.98%6.38%11.65%12.13%13.89%14.38%
Net Income13.90M25.26M40.91M60.42M60.68M47.25M17.11M12.28M12.78M1.83M-9.11M38.79M61.65M25.80M43.95M
Net Income Margin10.42%11.88%14.88%20.04%21.88%17.52%6.35%6.04%5.35%0.72%-3.16%4.85%5.71%2.48%4.96%
R&D-6.43M8.11M9.81M10.19M6.36M6.14M6.73M7.41M5.97M6.70M27.12M30.17M24.07M27.15M
R&D as % of Total Revenue-3.02%2.95%3.25%3.67%2.36%2.28%3.31%3.10%2.34%2.33%3.39%2.79%2.32%3.06%
Interest Expense785.66K765.03K959.75K133.42K1.14M815.68K412.55K409.59K754.62K2.12M562.29K29.78K4.06M3.31M2.66M
Interest Expense % of Total Revenue0.59%0.36%0.35%0.04%0.41%0.30%0.15%0.20%0.32%0.83%0.20%0.00%0.38%0.32%0.30%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets120.49M294.53M453.96M478.49M646.74M763.48M782.23M778.51M810.15M866.66M824.07M912.79M1.34B1.40B1.39B
Total Liabilities75.15M123.07M135.04M115.40M241.17M59.74M70.04M57.68M71.26M127.53M91.24M149.66M625.14M674.39M613.42M
Total Equity45.17M171.46M318.92M363.10M405.57M703.74M712.19M720.83M730.56M729.36M720.25M746.08M633.71M662.28M708.45M
Cash9.63M120.97M233.03M183.83M142.04M124.30M58.59M63.03M51.63M118.19M99.12M97.83M288.95M289.65M241.33M
Total Debt6.50M20.00M50.00M50.00M170.00M2.19M10.00M10.00M24.03M70.07M--143.35M98.41M-
Net Debt-3.13M-100.97M-183.03M-133.83M27.96M-122.11M-48.59M-53.03M-27.60M-48.12M-99.12M-97.83M-145.60M-191.24M-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow10.16M35.62M35.92M39.01M30.60M13.14M-2.05M10.23M28.21M43.50M51.13M11.43M96.53M170.14M-6.54M
Investing Cash Flow-12.21M-23.06M-58.00M-76.55M-166.38M-105.23M-54.78M-1.76M-50.12M-17.95M397.65K-12.71M-126.36M-77.62M-
Financing Cash Flow9.62M98.78M134.14M-11.65M94.00M74.36M-8.89M-4.03M10.52M41.01M-70.60M-19.17M-50.72M-91.57M-
Capital Expenditure12.21M24.15M60.94M99.35M164.66M53.03M55.72M2.78M28.52M18.55M413.70K13.63M126.36M78.22M43.36M
Free Cash Flow-2.04M11.47M-25.02M-60.35M-134.06M-39.90M-57.77M7.46M-314.83K24.95M50.72M-2.20M-29.83M91.93M-49.90M
Dividends Paid808.09K7.28M12.42M19.49M25.70M7.32M8.67M4.03M3.03M3.03M534.97K494.97K3.82M15.29M14.83M
FCF to OCF-20.12%32.20%-69.67%-154.70%-438.07%-303.72%2813.07%72.87%-1.12%57.35%99.19%-19.24%-30.91%54.03%763.34%
Dividend Paid to FCF-39.52%63.48%-49.63%-32.30%-19.17%-18.34%-15.00%54.07%-963.51%12.16%1.05%-22.51%-12.79%16.64%-29.72%

Earnings

Report DateOct 25, 2016Mar 3, 2017Apr 20, 2017Aug 15, 2017Oct 25, 2017Feb 14, 2018Apr 21, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 25, 2020Aug 22, 2020Oct 24, 2020Mar 16, 2021Apr 29, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Feb 26, 2024May 15, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 15, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------
EPS Actual0.040.030.030.02-0.000.010.020.01-0.000.010.020.00-0.010.020.00-0.04-0.010.050.000.00-0.03-0.000.000.000.010.070.070.040.050.050.07-0.000.010.000.080.01-0.000.060.08-0.04
Surprise----------------------------------------
TimingPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market----------------------After-hoursAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap3.82B
Enterprise Value4.12B
Trailing P/E114.36
Forward P/E0.00
Price / Sales5.17
Price / Book5.82
EPS0.11
Book Value2.36
Revenue (TTM)737.90M
Gross Profit (TTM)489.07M
EBITDA106.66M
Profit Margin4.68%
Operating Margin-1.65%
Return on Equity7.05%
Return on Assets2.90%
Shares Outstanding303.35M
Shares Float187.15M
Beta0.22
Dividend Yield0.32%
Dividend Rate0.04
Payout Ratio20.43%

Dividends

20261×
0.02May 22, 2026
20252×
0.02Sep 24, 20250.02May 28, 2025
20242×
0.02Sep 27, 20240.02Jun 6, 2024
20201×
0.01May 27, 2020
20191×
0.01May 16, 2019
20181×
0.01May 16, 2018
20171×
0.03May 10, 2017

Stock Splits

  • May 10, 201735:10